{
  "schemaVersion" : 2,
  "registerId" : "F2018C00853",
  "instrumentNumber" : "7/2018",
  "citation" : "Statement of Principles concerning migraine (Reasonable Hypothesis) (No. 7 of 2018)",
  "conditionName" : "migraine",
  "effectiveFrom" : "2018-01-29",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "G43"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "9(1)",
    "text" : "undergoing treatment with a nitric oxide donor, at the time of the\r\nclinical onset of migraine",
    "definedTerms" : [ {
      "term" : "nitric oxide donor",
      "definition" : "means a pharmacologically active substance that releases"
    } ]
  }, {
    "paragraph" : "9(2)",
    "text" : "having severe and persistent asthma within the five years before the\r\nclinical onset of migraine;\r\n(2a) having concussion or moderate to severe traumatic brain injury before\r\nthe clinical onset of migraine, where migraine has developed within the\r\nseven days of:\r\n(a) injury to the head; or\r\n(b) regaining consciousness following the injury to the head; or\r\n(c) discontinuing medication that impairs the ability to sense or\r\nreport headache following the injury to the head",
    "definedTerms" : [ {
      "term" : "severe and persistent asthma",
      "definition" : "means asthma having any of the following\r\nspecified characteristics, alone or in combination, for a cumulative period of\r\nat least six months within a continuous one year period:\r\n(a) FEV1 (forced expiratory volume in one second) of 60% or less of\r\nexpected value;\r\n(b) wheeze, tightness, cough, dyspnoea or other symptoms occurring\r\nthroughout each day;\r\n(c) frequent flare-ups;\r\n(d) the presence of night-time symptoms on more than one night per week;\r\nor\r\n(e) symptoms frequently restrict activity or sleep."
    } ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "9(3)",
    "text" : "undergoing treatment with a nitric oxide donor, at the time of the\r\nclinical worsening of migraine",
    "definedTerms" : [ {
      "term" : "nitric oxide donor",
      "definition" : "means a pharmacologically active substance that releases"
    }, {
      "term" : "clinical worsening of migraine",
      "definition" : "means a change in the nature of the migraine\r\nresulting in one or more of the following:\r\n(a) attacks of migraine that are increased in frequency by a factor of two-\r\nfold or more;\r\n(b) attacks of migraine that are increased in severity with debilitating,\r\nlong-lasting symptoms including nausea, vomiting, photophobia or\r\nphonophobia;\r\n(c) a conversion from episodic to chronic migraine;\r\n(d) an increase in the requirement for hospitalisation for management of\r\nthe manifestations or complications of migraine; or\r\n(e) an episode of severe migraine resulting in status migrainosus, cerebral\r\ninfarct, seizure or death.\r\nNote: chronic migraine is also defined in the Schedule 1 - Dictionary.\r\nmigraine—see subsection 7(2)."
    } ]
  }, {
    "paragraph" : "9(4)",
    "text" : "having severe and persistent asthma within the five years before the\r\nclinical worsening of migraine;\r\n(4a) having concussion or moderate to severe traumatic brain injury before\r\nthe clinical worsening of migraine, where migraine has worsened\r\nwithin the seven days of:\r\n(a) injury to the head; or\r\n(b) regaining consciousness following the injury to the head; or\r\n(c) discontinuing medication that impairs the ability to sense or\r\nreport headache following the injury to the head",
    "definedTerms" : [ {
      "term" : "severe and persistent asthma",
      "definition" : "means asthma having any of the following\r\nspecified characteristics, alone or in combination, for a cumulative period of\r\nat least six months within a continuous one year period:\r\n(a) FEV1 (forced expiratory volume in one second) of 60% or less of\r\nexpected value;\r\n(b) wheeze, tightness, cough, dyspnoea or other symptoms occurring\r\nthroughout each day;\r\n(c) frequent flare-ups;\r\n(d) the presence of night-time symptoms on more than one night per week;\r\nor\r\n(e) symptoms frequently restrict activity or sleep."
    }, {
      "term" : "clinical worsening of migraine",
      "definition" : "means a change in the nature of the migraine\r\nresulting in one or more of the following:\r\n(a) attacks of migraine that are increased in frequency by a factor of two-\r\nfold or more;\r\n(b) attacks of migraine that are increased in severity with debilitating,\r\nlong-lasting symptoms including nausea, vomiting, photophobia or\r\nphonophobia;\r\n(c) a conversion from episodic to chronic migraine;\r\n(d) an increase in the requirement for hospitalisation for management of\r\nthe manifestations or complications of migraine; or\r\n(e) an episode of severe migraine resulting in status migrainosus, cerebral\r\ninfarct, seizure or death.\r\nNote: chronic migraine is also defined in the Schedule 1 - Dictionary.\r\nmigraine—see subsection 7(2)."
    } ]
  }, {
    "paragraph" : "9(5)",
    "text" : "being obese for at least the five years before the clinical worsening of\r\nmigraine",
    "definedTerms" : [ {
      "term" : "being obese",
      "definition" : "means having a Body Mass Index (BMI) of 30 or greater.\r\nNote: BMI is also defined in the Schedule 1 - Dictionary."
    } ]
  }, {
    "paragraph" : "9(6)",
    "text" : "inability to obtain appropriate clinical management for migraine",
    "definedTerms" : [ ]
  } ]
}